Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/214407
Title: Exploring the Associations of Inflammatory and Oxidative Stress Biomarkers with Pancreatic Diseases: An Observational and Mendelian Randomisation Study
Author: Vilà-quintana, Laura
Fort, Esther
Pardo, Laura
Albiol-quer, Maria T.
Ortiz, Maria Rosa
Capdevila, Montserrat
Feliu, Anna
Bahí, Anna
Llirós, Marc
Aguilar, Esther
García-velasco, Adelaida
Ginestà, Mireia M.
Laquente, Berta
Pozas, Débora
Lluansí, Aleix
Pimenoff, Ville Nikolai
Moreno, Victor
Garcia-gil, Libadro Jesús
Duell, Eric J.
Carreras-torres, Robert
Aldeguer, Xavier
Issue Date: 12-Apr-2024
Publisher: MDPI AG
Abstract: Identifying biomarkers linked to pancreatic ductal adenocarcinoma (PDAC) and chronic pancreatitis (CP) is crucial for early detection, treatment, and prevention. Methods: Association analyses of 10 serological biomarkers involved in cell signalling (IFN-gamma, IL-6, IL-8, IL-10), oxidative stress (superoxide dismutase (SOD) and glutathione peroxidase (GPx) enzyme activities, total glutathione (GSH), malondialdehyde (MDA) levels), and intestinal permeability proteins (zonulin, I-FABP2) were conducted across PDAC (n = 12), CP (n = 21) and control subjects (n = 23). A Mendelian randomisation (MR) approach was used to assess causality of the identified significant associations in two large genetic cohorts (FinnGen and UK Biobank). Results: Observational results showed a downregulation of SOD and GPx antioxidant enzyme activities in PDAC and CP patients, respectively, and higher MDA levels in CP patients. Logistic regression models revealed significant associations between CP and SOD activity (OR = 0.21, 95% CI [0.05, 0.89], per SD), GPx activity (OR = 0.28, 95% CI [0.10, 0.79], per SD), and MDA levels (OR = 2.05, 95% CI [1.36, 3.08], per SD). MR analyses, however, did not support causality. Conclusions: These findings would not support oxidative stress-related biomarkers as potential targets for pancreatic diseases prevention. Yet, further research is encouraged to assess their viability as non-invasive tools for early diagnosis, particularly in pre-diagnostic CP populations.
Note: Reproducció del document publicat a: https://doi.org/10.3390/jcm13082247
It is part of: Journal of Clinical Medicine, 2024, vol. 13, issue. 8, p. 2247
URI: http://hdl.handle.net/2445/214407
Related resource: https://doi.org/10.3390/jcm13082247
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
jcm-13-02247.pdf694.26 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.